September 2024 – Page 52

A Culinary Feast To Rekindle The Historical Richness Of South African Delicacies By Brendi Wells

Sep 17, 2024 – We all have cherished memories of gatherings, whether with family, friends, or loved ones, that evoke a wide range of emotions. But do you know what is the one thing that seamlessly connects them all? Food!

Food is the one thing that seamlessly unites us at the table: a shared human experience that reflects the distinctive culture and traditions that are marked by our unique heritage and history.

And to rekindle the same heritage and culture, Brendi Wells is here to present her unique book “SURVIVAL FOOD: SOUTH AFRICAN PIONEER HISTORY AND CUISINE.”

With more than 100 recipes, Brendi emphasises the rich culinary history of South Africa, specifically traditional dishes that have been in the family for many generations. From traditional and unique Biltong and Potbrood to Soups & Stews, and Desserts, each recipe will not only share the secrets of cooking but also highlight the rich history and origin behind these traditional delicacies.

This book goes beyond simply teaching you how to cook. Instead, it is about connecting with South Africa’s vibrant culture and history through its food. By exploring traditional dishes and their origins, you’ll actually learn about the roots and perseverance of the people who shaped this incredible country into what we see now.

“SURVIVAL FOOD: SOUTH AFRICAN PIONEER HISTORY AND CUISINE” features a treasure trove of authentic recipes passed down through generations, ensuring culinary heritage is preserved that will highlight:

Family-favorite dishes: Learn to recreate traditional meals that have been enjoyed for generations, fostering a sense of connection and nostalgia.

Historical context: Explore the fascinating journey of South African cuisine, from its indigenous roots to the influences of settlers, highlighting the resourcefulness and resilience of past communities.

The power of community: Uncover how shared meals have served as a cornerstone of South African culture, fostering connection and celebrating traditions.

Cultural significance: Go deeper than just ingredients by exploring the stories and symbolism woven into each dish, revealing the unique blend of cultures that shaped South Africa’s culinary identity.

Practical techniques: Master the art of resourceful cooking, learning how to utilize local and everyday ingredients to create nourishing and delicious meals.

Recipes for modern kitchens: Discover how these traditional methods can be adapted for today’s contemporary kitchens, empowering home cooks and other skilled chefs to recreate these dishes and embrace South African flavors for a more tasty and delicious experience.

So, are you ready to unearth the stories embedded in these recipes, fostering a connection to your roots and South Africa’s rich culinary heritage?

“SURVIVAL FOOD: SOUTH AFRICAN PIONEER HISTORY AND CUISINE” offers a unique perspective on South African cuisine, allowing you to connect with the past, celebrate the present, and create lasting culinary memories.

Book Name: Survival Food: South African Pioneer Cuisine

Author Name: Brendi Wells

ISBN Number: 979-8218337629

Kindle Version: Click Here

Paperback Version: Click Here

Hardcover Version: Click Here

Media Contact
Company Name: Author Book Publications
Email: Send Email
Phone: +1-213-734-5719
Address:2333 Alexandria Dr
City: Lexington
State: Kentucky
Country: United States
Website: https://authorbookpublications.com/

Golden Care Remains Consistent in Offering the Best Caregivers at Home in San Diego, CA

Golden Care in San Diego, CA remains a top home care agency by providing exceptional, personalized care from the best caregivers. Offering tailored care plans for various needs, from basic companionship to specialized care, their dedicated team improves seniors’ quality of life while maintaining their independence and dignity at home. Visit https://getgoldencare.com to learn more about their commitment to compassionate, professional home care services in San Diego.

San Diego, CA – Golden Care, a leading provider of in-home care services, continues to uphold its reputation as one of the top home care agencies in San Diego. Under the leadership of Porsha Vogt, the company remains committed to offering exceptional care by providing the best caregivers to families in need across the region.

Golden Care’s unwavering dedication to excellence ensures that clients receive personalized, compassionate, and professional care in the comfort of their own homes. By consistently delivering top-tier caregiving services, Golden Care continues to set the standard in the home care industry, solidifying its position as one of the best home care agencies in San Diego.

“We are dedicated to maintaining the highest standards of care and service,” said Golden Care’s owner, Porsha Vogt. “Our caregivers are not only highly trained and experienced, but they are also genuinely passionate about improving the quality of life for our clients. It’s this combination of expertise and compassion that allows us to continue to be one of the most trusted names in home care in San Diego.”

Having a caregiver at home can significantly improve the quality of life for seniors by offering personalized assistance with daily activities, allowing them to maintain their independence and dignity. Caregivers provide support with tasks such as bathing, dressing, meal preparation, and medication management, which can help prevent accidents and reduce the stress associated with these activities. This support allows seniors to remain in their own homes, surrounded by familiar environments, which has been shown to impact their mental and emotional well-being positively.

In addition to physical support, in-home caregivers provide much-needed companionship for seniors who may otherwise experience feelings of loneliness and isolation. Regular interaction with a compassionate caregiver can help alleviate these feelings, promoting a sense of belonging and purpose. This social connection is crucial for maintaining mental health and can lead to a more fulfilling and happier life for seniors.

Moreover, caregivers can act as a bridge between seniors and their families, keeping loved ones informed about any changes in health or behavior. This communication ensures that families remain involved in the care process, giving them peace of mind that their loved ones are receiving the best possible care. By having a caregiver at home, families can trust that their loved ones are in good hands, allowing them to focus on their own well-being while knowing their family members are safe and well-cared for.

Golden Care’s services cater to a wide range of needs, from basic companionship and personal care to more specialized care for individuals with chronic illnesses or those recovering from surgery. The company’s comprehensive approach ensures that each client receives a care plan tailored to their unique needs, fostering a sense of independence and dignity.

For more information about Golden Care and its home care in San Diego, please visit their website at https://getgoldencare.com

About Golden Care:

Golden Care is a premier home care agency in San Diego, CA, offering a wide range of in-home care services designed to meet the unique needs of each client. With a focus on providing compassionate and professional care, Golden Care is committed to improving the quality of life for its clients while enabling them to maintain their independence in the comfort of their own homes.

Media Contact
Company Name: Golden Care
Contact Person: Porsha Vogt
Email: Send Email
Phone: +1 760 828 5201
Address:5055 Avenida Encinas Suite #240
City: Carlsbad
State: CA
Country: United States
Website: https://getgoldencare.com/

Specialist AI Team from “PersonalAIze” Highlights the Strength, Potential and Visionary Talent Behind Software as a Service (SaaS) Platform for Early Cancer Detection: Renovaro, Inc. (Nasdaq: RENB)

Renovaro, Inc. (Nasdaq: RENB) aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. RENB includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube.

RENB RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective.

RENB RenovaroCube is a molecular data science company with a background in FinTech and a 12-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.

Independent Expert Assessment Validates RENB RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform

PersonalAIze, a cutting-edge company in AI and machine learning applications for healthcare, has conducted a comprehensive evaluation of the RENB RenovaroCube’s advanced AI platform. This effort is spearheaded by PersonalAIze CEOs and AI experts, Mark Hoogendoorn and Sandjai Bhulai, who bring their extensive expertise to assess the platform developed under the guidance of Frank van Asch, CTO and co-Founder of the technology on which the RENB RenovaroCube is based.

Prof. Mark Hoogendoorn, also a professor of Artificial Intelligence, expressed his enthusiasm: “We were pleased to be engaged to make an assessment of the AI platform; this is exactly the area of PersonalAIze’s expertise.”

Frank van Asch remarked on the collaboration, “The expertise of PersonalAIze’s team is exceptional, and their positive evaluation of our AI/ML platform is invaluable.”

The RENB RenovaroCube AI platform has been advancing innovation for the past 12 years, evolving from its award-winning Fintech roots into a potentially groundbreaking multi-omic molecular differential system that identifies cancer in its earliest stages. It is an open platform that can be used as a SaaS by many private sector and academic or other large hospital and health systems. It is also disease agnostic, so it can be expanded for many purposes.

The initial aim for RENB is to transform cancer early detection and early detection of recurrence from a small vial of blood (liquid biopsy), potentially supporting clinicians to initiate treatments as soon as possible towards improved outcomes for patients.

In their analysis, PersonalAIze noted the RENB platform’s focus on liquid biopsies and third-generation sequencing coupled with AI techniques as highly promising, potentially allowing for comprehensive analysis across varying cancer types and stages. Prof. Sandjai Bhulai, also a professor of Mathematics, commented on the platform’s unique potential and the impressive multidisciplinary team at RenovaroCube under Frank van Asch’s leadership.

Based on these findings, PersonalAIze is eager to collaborate further with RENB RenovaroCube to enhance and commercialize the platform.

PersonalAIze aims to contribute in several key areas:

Advancing AI models by leveraging the latest state-of-the-art techniques.

Enhancing the explainability of AI models, engaging clinicians in model development.

Selecting optimal patient groups for data collection and evaluating models and final products in clinical settings.

This partnership for RENB could represent a substantial step forward in the fight against cancer, bringing together AI innovation and healthcare expertise to develop a powerful tool for early detection that has the potential to save countless lives.

RENB RenovaroCube Presented Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

RENB has presented two scientific presentations at a leading cancer conference – the European Society for Medical Oncology (ESMO) Congress – on September 15, 2024.

One RENB presentation describes the development of a deep learning model that leverages cell-free DNA (cfDNA) fragmentation features (fragmentomics) from a small sample of blood to detect cancer. The results show that in comparison to state-of-the-art cfDNA cancer detection models, we were able to perform on par while utilizing only minute amounts of genetic data. The integration of fragmentomics into the Cube’s current platform, further enhances its capacity to detect cancer, potentially leading to earlier and/or better treatment options and improved patient outcomes.

A second RENB study demonstrated the Cube platform’s ability to correlate methylation patterns from cancer tissue in cfDNA derived from plasma, indicating that cancer can be detected in blood samples as an alternative for invasive tissue biopsies.

To Review $RENB visit: http://www.renovarobio.com and https://compasslivemedia.com/renb/

Disclaimer and Disclosure: www.aibrandnetwork.com

Media Contact
Company Name: Renovaro Biosciences Inc
Contact Person: The Hon. Mark Dybul, MD, CEO
Email: Send Email
Phone: 732-780-5036
Address:2080 Century Park East Suite 906
City: Los Angeles
State: California 90067
Country: United States
Website: https://www.enochianbio.com/overview/default.aspx

Idiopathic Membranous Nephropathy Treatment Market Size in the 7MM is expected to reach ~USD 1,000 million by 2034

Idiopathic Membranous Nephropathy Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Idiopathic Membranous Nephropathy Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.

DelveInsight’s “Idiopathic Membranous Nephropathy Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of Idiopathic Membranous Nephropathy (IMN), historical and forecasted epidemiology as well as the Idiopathic Membranous Nephropathy (IMN) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Unlock detailed insights into the Idiopathic Membranous Nephropathy Market by downloading the comprehensive report from DelveInsight @ Idiopathic Membranous Nephropathy Therapeutics Market

Key Takeaways from the Idiopathic Membranous Nephropathy Market Report

In September 2024:-Shanghai Jiaolian Drug Research and Development Co., Ltd- A Multicenter, Randomized, Controlled, Open Phase II/III Clinical Study to Evaluate the Efficacy and Safety of B007 Versus Cyclosporine in the Treatment of Primary Membranous Nephropathy. To evaluate the efficacy and safety of B007 in the Treatment of Primary Membranous Nephropathy.
In August 2024:- BeiGene- The primary objectives of this study are: In Part 1 to evaluate the efficacy of zanubrutinib as measured by proteinuria reduction, and in Part 2 to evaluate the efficacy of zanubrutinib compared with tacrolimus as measured by complete remission rate, in participants with primary membranous nephropathy who are on optimal supportive care.
In 2023, the US accounted for ~40% of all Idiopathic Membranous Nephropathy prevalent cases in 7MM.
Japan’s data suggests a relatively stable trend in the Idiopathic Membranous Nephropathy prevalence over the forecasted period of 2024-2034.
Germany had the highest Idiopathic Membranous Nephropathy prevalence among EU4 and the UK, accounting for ~30% of cases, followed by the UK with ~20%, in 2023.
In 2023, the PLA2R-specific cases in EU4 and the UK contributed ~75% in the 7MM.
The leading Idiopathic Membranous Nephropathy Companies such as SynAct Pharma Aps, argenx, Shanghai Jiaolian Drug Research and Development Co., Ltd, Beijing Mabworks Biotech Co., Ltd., Cerium Pharmaceuticals, Inc., BeiGene, Reistone Biopharma Company Limited, Hoffmann-La Roche, Alpine Immune Sciences, Inc., Walden Biosciences, and others.
Promising Idiopathic Membranous Nephropathy Therapies such as WAL0921, povetacicept, Belimumab, Obinutuzumab, Methylprednisolone, Tacrolimus, and others.

Gain a competitive edge in the Idiopathic Membranous Nephropathy Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Idiopathic Membranous Nephropathy Treatment Drugs

Idiopathic Membranous Nephropathy Epidemiology Segmentation in the 7MM

Total Idiopathic Membranous Nephropathy prevalent cases
Idiopathic Membranous Nephropathy antigen-specific cases
Total Idiopathic Membranous Nephropathy treated cases

Idiopathic Membranous Nephropathy Market Insights

Membranous nephropathy (MN) is an autoimmune disease caused by antibodies mostly directed to podocyte antigens and characterized by very high levels of protein in the urine, edema, hypoalbuminemia, and elevated serum lipids. MN is typically divided into primary MN (Idiopathic membranous nephropathy) when there is no underlying disease association and secondary MN when there is an underlying disease association such as autoimmune disease (most commonly lupus), malignancy, infection, or temporal association with the use of certain drugs. The short-term goal of treatment is to stop protein spillage completely (known as remission) or lower the amount of protein lost in the urine as much as possible. The less protein lost in the urine, the better the individual will do. The long-term treatment goals, including protein relapses in the urine and preventing the deterioration of kidney function.

Discover key developments and opportunities in the Idiopathic Membranous Nephropathy Market. Click here to learn more from DelveInsight’s latest report @ Idiopathic Membranous Nephropathy Market Size

Idiopathic Membranous Nephropathy Emerging Drugs

GAZYVA (obinutuzumab): Hoffmann-La Roche
SNP-ACTH (1-39) Gel: Cerium Pharmaceuticals

Idiopathic Membranous Nephropathy Drugs Uptake

Idiopathic Membranous Nephropathy pipeline possesses some drugs in mid- and late stage developments to be approved in the near future. Expected launch of emerging therapies, such as GAZYVA (obinutuzumab) by Hoffmann-La Roche, MOR202 (felzartamab) by MorphoSys/HI-Bio, MOR202 (felzartamab) by MorphoSys/HI-Bio, BRUKINSA (zanubrutinib) by BeiGene and others shall further create a positive impact on the market.

Download DelveInsight’s Idiopathic Membranous Nephropathy Market report today and stay ahead in this rapidly evolving field. @ Idiopathic Membranous Nephropathy Clinical Trials

Scope of the Idiopathic Membranous Nephropathy Market Report

Coverage- 7MM
Idiopathic Membranous Nephropathy Companies- SynAct Pharma Aps, argenx, Shanghai Jiaolian Drug Research and Development Co., Ltd, Beijing Mabworks Biotech Co., Ltd., Cerium Pharmaceuticals, Inc., BeiGene, Reistone Biopharma Company Limited, Hoffmann-La Roche, Alpine Immune Sciences, Inc., Walden Biosciences, and others.
Idiopathic Membranous Nephropathy Therapies- WAL0921, povetacicept, Belimumab, Obinutuzumab, Methylprednisolone, Tacrolimus, and others.
Idiopathic Membranous Nephropathy Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
Idiopathic Membranous Nephropathy Unmet Needs, KOL’s views, Analyst’s views, Idiopathic Membranous Nephropathy Market Access and Reimbursement

Download the report to understand which factors are driving Idiopathic Membranous Nephropathy Market Trends @ Idiopathic Membranous Nephropathy Market Trends

Table of Content

1. Key Insights

2. Report Introduction

3. Idiopathic Membranous Nephropathy (IMN) Market Overview at a Glance

4. Methodology

5. Executive Summary of IMN

6. Key Events

7. Disease Background and Overview

8. Treatment and Management

9. Epidemiology and Patient Population

10. Patient Journey

11. Emerging Therapies

12. Market Analysis

13. KOL Views

14. SWOT Analysis

15. Unmet Needs

16. Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Idiopathic Membranous Nephropathy Treatment Market Size in the 7MM is expected to reach ~USD 1,000 million by 2034

Revenue in the Blood Glucose Monitoring Devices Market Set to Surge Twofold, $52.46 Billion Worth of Opportunities Anticipated in the Next 6 Years – Arizton Advisory & Intelligence

“The global blood glucose monitoring devices market was valued at USD 25.62 billion in 2023 and is expected to reach USD 52.46 billion by 2029, growing at a CAGR of 12.69% during the forecast period.?”

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.

According to Arizton’s latest research report, the global blood glucose monitoring devices market (BGM) is growing at a CAGR of 12.69% during 2023-2029.

Looking for More Information? Click: https://www.arizton.com/market-reports/blood-glucose-monitoring-devices-market-2024

Report Scope:  

Market Size (2029): $52.46 Billion      

Market Size (2023): $25.62 Billion      

CAGR (2023-2029): 12.69%       

Historic Year:  2020-2022          

Base Year: 2023          

Forecast Year: 2024-2029          

Market Segmentation: Product Type, Conventional Blood Glucose Monitoring Devices, Continuous Glucose Monitoring (CGM) Devices, Usage, Distribution Channel, End-Users, and Geography

Geographical Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa  

Book the Free Sample Now: https://www.arizton.com/market-reports/blood-glucose-monitoring-devices-market-2024

Flash Glucose Monitoring: An Emerging Trend in BGM Devices Market

Flash glucose monitoring (FGM) is quickly becoming a game-changer in diabetes management, offering a more advanced way to track glucose levels throughout the day and night. This innovative technology, a type of continuous glucose monitoring (CGM), allows users to check their glucose levels simply by scanning, providing greater control over how often and when they monitor their glucose.

Recent studies highlight significant improvements in glucose control for patients with severe glucose level fluctuations using FGM technology. Real-world applications show that FGM can reduce both hypoglycemia and hyperglycemia, particularly benefiting high-risk individuals. Notably, Abbott’s FreeStyle Libre has demonstrated a positive impact on managing type 1 diabetes, including during pregnancy, while also proving to be a cost-effective alternative to traditional self-monitoring systems.

Abbott’s FreeStyle Libre, launched in 2020, has seen remarkable adoption with over 500,000 users, thanks to its no-fingerstick calibration feature and its 8-hour glucose monitoring capability. The water-resistant sensors, typically worn on the back of the upper arm or abdomen, last between 3 to 14 days. For patients with type 1 and type 2 diabetes, especially those on sulfonylureas or intensive insulin therapy, FGM presents a more economical option compared to traditional blood glucose monitoring and continuous glucose monitoring systems. The expanding patient population and the associated cost benefits signal a promising future for this technology.

Watch Out Recent Activities by Market Vendors

In 2024, MTD Group acquired the pen needle and blood glucose monitoring systems of Ypsomed, as well as announced significant investment for its European product sites.
In 2023, Abbott acquired Bigfoot Biomedical, one of the leading manufacturers of smart insulin management systems. This transaction strengthened Abbott’s FreeStyle Libre CGM technology, helping it increase its presence in diabetes care.
In 2023, Medtronic entered into a set of definitive agreement to acquire EoFlow Co. Ltd., a pioneer in insulin delivery devices. Medtronic’s meal detection technology algorithm and next-generation CGM are expected to expand the company’s ability to deliver diabetes care solutions.

Product Launched & Development

In June 2024, Prevounce Health launched a technologically advanced, cellular-connected blood glucose meter for remote patient monitoring. It is a rigorously tested and FDA-approved device widely available in the US and global markets.
In May 2024, Smart Meter launched an iGlucose Plus glucose monitoring device globally. It is a handheld device connected to a smartphone and Wi-Fi systems.
In Feb 2024, Dexcom launched Dexcom ONE+, a real-time and customized glucose monitoring device that can be worn in three different body locations. Furthermore, it has a water-resistant sensor that enhances its brand image.

Which are the Top Companies in the Blood Glucose Monitoring Devices Market?     

Key Vendors

F. Hoffmann-La Roche
Abbott
Dexcom
Medtronic
Ascensia Diabetes Care Holdings AG
LifeScan IP Holdings
Arkray
ApexBio
ACON Laboratories, Inc.
AgaMatrix
Alliance International
Andon Health
Bionime
Beurer
Bioptik
BioTelemetry
BioTest Medical
BTNX
DarioHealth
EASYMAX
ForaCare
Hannox International
Integrity Applications
i-SENS
MED TRUST
Medisana
Nova Biomedical
Omnis Health
Nemaura
OK Biotech
OSANG Healthcare
Philosys
Sanofi
Taidoc Technology
Terumo Corporation
Trividia Health
Rossmax International
Ypsomed
77 Electronika Kft
Menarini Diagnostics

Market Segmentation Overview

Conventional BGM devices, which include test strips, meters, software, and lancet & lancing devices, currently hold the largest market share. Their long-standing use and familiarity in both patient and healthcare settings contribute to their dominance. BGM remains the most prevalent method for monitoring blood glucose, endorsed by health authorities globally. These devices are generally more cost-effective compared to CGM systems, leading to higher adoption rates. The total expense for test strips and BGM devices is significantly lower than that for CGM systems, and the growth of self-monitoring practices further fuels the market for BGM. BGM provides personalized treatment and management for a substantial portion of the diabetes population, offering immediate results that help patients adjust insulin dosages promptly and effectively.

The individual segment is expected to experience the highest growth in the global blood glucose monitoring devices market during the forecast period. Diabetes poses a significant global public health challenge, particularly impacting developing countries where high morbidity and mortality rates are exacerbated by inadequate management and noncompliance with guidelines. Studies reveal that poor diabetes management leads to extremely negative health outcomes, driving diabetic patients to frequently self-test their glucose levels.

Screening large populations for diabetes can be prohibitively expensive and challenging due to the high cost of diagnostic tests and a shortage of healthcare personnel, both in developed and developing countries. In response to these obstacles, patients are increasingly turning to self-monitoring blood glucose devices. Governments and insurance providers are supporting this shift by covering the costs of these devices, further propelling growth in this segment.

Segmentation & Forecast

Product Type

Conventional Blood Glucose Monitoring Devices
Continuous Glucose Monitoring (CGM) Devices

Conventional Blood Glucose Monitoring Devices

Test Strips
Meter & Software
Lancet & Lancing Devices

Continuous Glucose Monitoring (CGM) Devices

Sensors
Reusable Hardware

Usage

Personal BGM Devices
Professional BGM Devices

Distribution Channel

Offline
Online

End-Users

Individuals
Hospitals & Clinics
Other End-users

Geography

North America
The U.S.
Canada
Europe
Germany
The U.K.
France
Italy
Spain
APAC
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Columbia
Argentina
Middle East & Africa
Turkey
South Africa
Saudi Arabia

In a nutshell, the Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the blood glucose monitoring devices market. Request for Free Sample to get a glance of the report now: https://www.arizton.com/market-reports/blood-glucose-monitoring-devices-market-2024

What Key Findings Will Our Research Analysis Reveal?

How big is the global blood glucose monitoring devices market?

What is the growth rate of the global blood glucose monitoring devices market?

Who are the major players in the global blood glucose monitoring devices market?

Which region dominates the global blood glucose monitoring devices market?

Looking for Customization According to Your Business Requirement? https://www.arizton.com/customize-report/4487

Other Related Reports that Might be of Your Business Requirement

Blood Culture Tests Market – Global Outlook & Forecast 2024-2029

The global blood culture tests market was valued at USD 5.72 billion in 2023 and is expected to reach USD 8.98 billion by 2029, growing at a CAGR of 7.81% during the forecast period. Learn more about the market now: https://www.arizton.com/market-reports/blood-culture-tests-market

Europe Clinical Laboratory Tests Market – Focused Insights 2024-2029

The Europe clinical laboratory tests market size was valued at USD 59.06 billion in 2023 and is expected to reach USD 69.10 billion by 2029, growing at a CAGR of 2.65% during the forecast period. Explore! https://www.arizton.com/market-reports/europe-clinical-laboratory-tests-market

Why Arizton?                                           

100% Customer Satisfaction                                           

24×7 availability – we are always there when you need us                                           

200+ Fortune 500 Companies trust Arizton’s report                                           

80% of our reports are exclusive and first in the industry                                           

100% more data and analysis                                           

1500+ reports published till date                         

Post-Purchase Benefit                                       

1hr of free analyst discussion                                       
10% off on customization

About Us:                                                                                

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                              

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                               

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                     

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1-312-235-2040 /+1 302 469 0707   
Country: United States
Website: https://www.arizton.com/market-reports/blood-glucose-monitoring-devices-market-2024

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Revenue in the Blood Glucose Monitoring Devices Market Set to Surge Twofold, $52.46 Billion Worth of Opportunities Anticipated in the Next 6 Years – Arizton Advisory & Intelligence

Cooperative Home Care—St. Louis continues to prioritize Senior Care, offering 12 and 24-hour Home Care Services in Clayton, MO.

Cooperative Home Care – St. Louis continues to meet the growing demand for 12 & 24-hour home care in Clayton, MO. Offering personalized care plans, assistance with daily activities, and constant supervision, their dedicated caregivers ensure seniors can live comfortably and safely at home while reducing hospitalizations and providing peace of mind for families. Visit https://cooperativehomecare.com to learn more about their top-quality, round-the-clock senior care services in Clayton.

Clayton, MO – Cooperative Home Care—St. Louis, a leading provider of senior care services, continues to meet the growing demand for 12- and 24-hour home care in Clayton, MO. With a steadfast commitment to providing top-quality care, the agency ensures that seniors receive the necessary support to maintain their independence and well-being in the comfort of their own homes.

“At Cooperative Home Care, our dedication to the Clayton community and its seniors remains unwavering. We understand the importance of providing continuous, personalized care that meets the unique needs of each individual. Our goal is to ensure that every senior under our care feels safe, supported, and valued around the clock,” said Mitch Waks, Cooperative Home Care – St. Louis owner.

In-home care is crucial in Clayton, where many families seek reliable services for their elderly loved ones. Cooperative Home Care—St. Louis responds to this need by offering tailored care plans that cater to seniors’ complex health needs. These plans allow seniors to live comfortably at home while reducing hospital visits and healthcare complications.

The 12- and 24-hour home care services provided by Cooperative Home Care—St. Louis is essential for seniors with chronic conditions or requiring constant supervision. This level of care ensures that clients receive timely assistance with daily activities such as bathing, dressing, medication management, and meal preparation, significantly improving their quality of life and preventing unnecessary hospitalizations.

Moreover, round-the-clock care offers peace of mind to families struggling to provide consistent care for their loved ones. Knowing that a professional caregiver is always available to address emergencies or sudden changes in health conditions offers invaluable relief for family members, allowing them to maintain a balanced life while ensuring their loved one is in good hands.

The importance of 12 and 24-hour care extends beyond physical health; it also plays a critical role in emotional and mental well-being. Regular interaction with caregivers helps combat loneliness and social isolation, common issues among the elderly. This comprehensive approach to care supports the overall happiness and stability of seniors, making it a crucial service for the aging population in Clayton.

Families in Clayton, MO, looking for dependable senior care services can rely on Cooperative Home Care – St. Louis. For more information about their 12 & 24-hour home care in Clayton, please visit their website at https://cooperativehomecare.com

About Cooperative Home Care—St. Louis:

Cooperative Home Care—St. Louis is a premier provider of senior care services dedicated to enhancing the quality of life for seniors in the Clayton, MO, area. With a team of experienced and compassionate caregivers, Cooperative Home Care offers a range of services designed to meet the diverse needs of the elderly community. Their ongoing commitment to providing exceptional care makes them a trusted choice for families seeking in-home support for their loved ones.

Media Contact
Company Name: Cooperative Home Care, Inc.
Contact Person: Mitch Waks
Email: Send Email
Phone: +1 314 772 8585
Address:1924 Marconi Ave
City: St. Louis
State: MO
Country: United States
Website: https://cooperativehomecare.com/

Seton Noble Launches Personal Website to Share Insights and Inspire Action

Seton Noble, a distinguished business student at the University of Western Ontario and a passionate community activist, is excited to announce the launch of his new personal website, SetonNoble.com. The website is designed to serve as a hub for sharing his journey, insights into the business world, sports experiences, and community service initiatives, including his annual clothing drive for the homeless.

Seton Noble’s new website features a variety of sections including a blog where Seton will share his thoughts on business trends, sports analysis, and effective community service strategies. Additionally, the site contains a detailed biography, a calendar of upcoming events, and a gallery of past activities and achievements.

“I am thrilled to launch my website, which I hope will serve as a source of inspiration and information for young individuals looking to make a difference in their communities,” said Seton. “Whether it’s sharing my latest project or reflecting on a basketball game, I look forward to connecting with others who share similar passions and goals.”

SetonNoble.com also provides resources for those interested in starting their own community initiatives, including how-to guides and tips for effective fundraising and event planning.

The website’s launch is just the beginning of Seton’s plans to expand his digital footprint and engage with a broader audience to foster a community of motivated, forward-thinking individuals who are eager to make a positive impact in the world.

For more information, to view the website, or to contact Seton Noble, please visit SetonNoble.com.

About Seton Noble:

Seton Noble is a business student at the University of Western Ontario, an accomplished athlete, and a committed community volunteer. Known for his leadership and dedication, Seton has been actively involved in various causes, particularly his notable work with annual clothing drives for the homeless in Toronto. His blend of academic rigor, sports enthusiasm, and community activism informs his mission to inspire and lead by example in both his personal and professional life.

Media Contact
Company Name: Seton Noble
Email: Send Email
City: Toronto
State: Ontario
Country: Canada
Website: setonnoble.com

Cardinal Senior Care Reinforces Its Commitment to San Antonio Families with Respite Care Services

Cardinal Senior Care in San Antonio, TX continues providing specialized respite care services to support family caregivers. Offering flexible, personalized care plans, their dedicated team ensures seniors receive top-tier care while caregivers take much-needed breaks to recharge. This improves caregivers’ well-being and prevents burnout. Visit https://cardinalseniorcare.com to learn more about their compassionate respite care designed to benefit both seniors and families in San Antonio.

San Antonio, TX – Cardinal Senior Care is proud to announce the continuation of its dedicated support to family caregivers in San Antonio through its specialized respite care services. As part of the company’s ongoing commitment to providing top-tier San Antonio home care, these services ensure that caregivers receive the much-needed breaks they deserve, allowing them to recharge while knowing their loved ones are in expert hands.

“At Cardinal Senior Care, we understand the immense dedication required to care for a loved one. Our respite care services are designed to provide relief for family members, ensuring they can rest and rejuvenate without compromising the quality of care their loved ones receive,” said Hamid Mangalji, owner of Cardinal Senior Care. “We are dedicated to offering reliable, compassionate, and professional care that allows families in San Antonio to maintain their well-being while ensuring their loved ones continue to receive exceptional support.”

This service is particularly beneficial for families with elderly members who require constant supervision and assistance, which can be exhausting for primary caregivers. Cardinal Senior Care’s respite services are tailored to meet the unique needs of each family, providing flexibility and peace of mind. Whether a few hours a day or several days a week, caregivers can trust that their loved ones will receive the highest standard of care in their absence.

Respite care provides invaluable benefits for both seniors and their families. For seniors, it offers a chance to engage with new caregivers, experience different activities, and enjoy a change of routine, all of which can enhance their emotional and mental well-being. Respite care also allows seniors to stay in their homes, surrounded by familiar environments and comforts, significantly contributing to their sense of security and overall happiness.

For family caregivers, respite care’s advantages cannot be overstated. Regular breaks from caregiving duties help prevent burnout, reduce stress, and improve overall health. It allows caregivers to return to their responsibilities refreshed with a renewed focus, ultimately leading to better care for their loved ones. During these breaks, family members can use the time to tend to their needs, reconnect with other family members and friends, or enjoy well-deserved relaxation.

Whether indulging in a favorite hobby, enjoying a peaceful afternoon, or spending quality time with other loved ones, respite care provides family caregivers the freedom to recharge. Cardinal Senior Care’s respite services are flexible, allowing families to schedule care according to their unique needs. This personalized approach ensures that seniors and caregivers receive the support they need when they need it most.

Families looking for reliable respite care in San Antonio, TX, can explore more about Cardinal Senior Care’s offerings by visiting their website at https://cardinalseniorcare.com

About Cardinal Senior Care:

Cardinal Senior Care is a leading provider of in-home senior care services in San Antonio, TX. With a reputation for excellence and compassion, the company offers a comprehensive range of services tailored to meet the diverse needs of the elderly community. Their commitment to enhancing the lives of seniors and supporting family caregivers makes them a trusted choice for those seeking quality respite and home care service.

Media Contact
Company Name: Cardinal Senior Care
Contact Person: Hamid Mangalji
Email: Send Email
Phone: +1 210 316 4818
Address:4402 Vance Jackson Rd Suite# 202
City: San Antonio
State: TX
Country: United States
Website: http://www.cardinalseniorcare.com

Schizophrenia Treatment Market Size in the 7MM was approximately USD 8000 Million in 2022

Schizophrenia Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Schizophrenia Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.

DelveInsight’s “Schizophrenia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Schizophrenia, historical and forecasted epidemiology, as well as the Schizophrenia market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Unlock detailed insights into the Schizophrenia Market by downloading the comprehensive report from DelveInsight @ Schizophrenia Therapeutics Market

Key Takeaways from the Schizophrenia Market Report

In August 2024:- CF Pharma LLC– An Open Non-comparative Clinical Trial of the Pharmacokinetics, Safety and Tolerability of VLT-015, Tablets, 100 mg (Valentech LLC) With Single and Multiple Use in Patients With Schizophrenia. 15 stable patients diagnosed with schizophrenia take 100 mg of VLT-015 once a day, 200 mg of VLT-015 once a day and 200 mg of VLT-015 on two consecutive days with an interval of 24 hours between doses. PK parameters are measured, tolerability and safety of the product are evaluated.
In August 2024:- Karuna Therapeutics:– A Phase 3b, Open-label, Multicenter, Two-Period, Slow-titration and Food Effect Study to Assess the Safety and Efficacy of KarXT in Participants With DSM-5 Schizophrenia. The purpose of this study is to assess the safety and efficacy of slowly increasing dose and food effect of KarXT in adult participants with schizophrenia.
The Schizophrenia Market Size in the 7MM will increase at a significant CAGR due to increasing prevalent cases of the disease and the launch of the emerging therapies.
As per DelveInsight analysis, in 2023 the total diagnosed prevalent cases of schizophrenia in the 7MM were found to be approximately 3.8 million cases out of which the US accounted for nearly 1.4 million cases. It is anticipated that these numbers will rise by 2034 owning to advancements in psychiatric research and diagnostic criteria, potentially resulting in a more precise identification and diagnosis of schizophrenia on a global scale.
Among the 7MM in the year 2023, EU4 and the UK accounted for nearly 42% of the total diagnosed prevalent cases of schizophrenia.
DelveInsight’s analysis suggests that males have a higher susceptibility to schizophrenia, influenced by genetic, hormonal, and neurodevelopmental factors. In 2023, the diagnosed prevalence of schizophrenia in the US was approximately 767 thousand for males and 664 thousand for females. Projections indicate that these figures may vary over the forecast period (2024-2034).
The leading Schizophrenia Companies such as Boehringer Ingelheim, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Karuna Therapeutics, Bristol Myers Squibb, Royalty Pharma, Acadia Pharmaceuticals, Rovi Pharmaceuticals Laboratories (Laboratorios Farmacéuticos Rovi), Teva Pharmaceutical, MedinCell, Lyndra Therapeutics, Neurocrine Biosciences, Mitsubishi Tanabe Pharma, Luye Pharma, Newron Pharmaceuticals, and others.
Promising Schizophrenia Therapies such as AQW051 2 mg (single and multiple doses), Seroquel Sustained Release (SR), LY2140023, Moxifloxacin, Olanzapine Hydrochloride, and others

Gain a competitive edge in the Schizophrenia Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Schizophrenia Treatment Drugs

Schizophrenia Epidemiology Segmentation in the 7MM

Total Prevalent Cases
Total Diagnosed Prevalent Cases
Gender-specific Diagnosed Prevalent Cases
Severity-specific Diagnosed Prevalent Cases

Schizophrenia Market Insights

The mainstay of treatment includes medication and psychosocial therapy that can help manage the condition. Pharmacological therapy plays a vital role in treating this disease, where many mono and combination pharmacological therapies are available for treating schizophrenia symptoms. Antipsychotics, recommended as first-line treatment for schizophrenia, divided into first-generation (FGAs) and second-generation (SGAs) categories, are the primary pharmacological interventions. For some patient groups, treatment strategies include a combination of neuroleptics and antiepileptic. Both oral antipsychotics (OAP) and long-acting injectable therapies (LAI) are available for each generation.

Discover key developments and opportunities in the Schizophrenia Market. Click here to learn more from DelveInsight’s latest report @ Schizophrenia Market Size

Schizophrenia Treatment Market Landscape

Schizophrenia treatment revolves around medication management, the precise kind and dosage of medication used will depend on several variables, including the severity of the symptoms, the response to treatment, and any possible side effects and comorbidities. In addition to pharmacotherapy, psychosocial interventions play a crucial role in addressing functional impairments and promoting recovery. These may include cognitive-behavioral therapy to target cognitive distortions and enhance coping skills, social skills training to improve interpersonal relationships and community integration, and supported employment or education programs to facilitate vocational or academic pursuits. Thus, understanding that every person’s path to wellness is different highlights the significance of providing patient-centered, holistic care that honors each person’s particular experiences and goals.

Schizophrenia Marketed Drugs

ABILIFY MAINTENA (aripiprazole): Otsuka Pharmaceutical/Lundbeck
UZEDY (risperidone): Teva Pharmaceuticals/MedinCell

Schizophrenia Emerging Drugs

Ulotaront (SEP-363856): Sumitomo Pharma/Otsuka Pharmaceuticals
Brilaroxazine (RP-5063): Reviva Pharmaceuticals

Download DelveInsight’s Schizophrenia Market report today and stay ahead in this rapidly evolving field. @ Schizophrenia Clinical Trials

Scope of the Schizophrenia Market Report

Coverage- 7MM
Schizophrenia Companies- Boehringer Ingelheim, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Karuna Therapeutics, Bristol Myers Squibb, Royalty Pharma, Acadia Pharmaceuticals, Rovi Pharmaceuticals Laboratories (Laboratorios Farmacéuticos Rovi), Teva Pharmaceutical, MedinCell, Lyndra Therapeutics, Neurocrine Biosciences, Mitsubishi Tanabe Pharma, Luye Pharma, Newron Pharmaceuticals, and others.
Schizophrenia Therapies- AQW051 2 mg (single and multiple doses), Seroquel Sustained Release (SR), LY2140023, Moxifloxacin, Olanzapine Hydrochloride, and others
Schizophrenia Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
Schizophrenia Unmet Needs, KOL’s views, Analyst’s views, Schizophrenia Market Access and Reimbursement

Download the report to understand which factors are driving Schizophrenia Market Trends @ Schizophrenia Market Trends

Table of Content

1. Key Insights

2. Report Introduction

3. Schizophrenia Market Overview at a Glance

4. Methodology of Schizophrenia Epidemiology and Market

5. Executive Summary of Schizophrenia

6. Key Events

7. Disease Background and Overview

8. Patient Journey

9. Epidemiology and Patient Population

10. Marketed Drugs

11. Emerging Drugs

12. Schizophrenia: Market Analysis

13. Key Opinion Leaders’ Views

14. SWOT Analysis

15. Unmet Needs

16. Market Access and Reimbursement

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

About Us

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Schizophrenia Treatment Market Size in the 7MM was approximately USD 8000 Million in 2022

Ishan Patel Featured in Exclusive Online Interview

Audien Hearing Reviews, Scottsdale, AZ, United States

Ishan Patel, the CEO and Co-Founder of Audien Hearing, has been featured in an exclusive interview on Inspirery, where he delves into his entrepreneurial journey, the founding of Audien Hearing,

Ishan Patel, the CEO and Co-Founder of Audien Hearing, has been featured in an exclusive interview on Inspirery, where he delves into his entrepreneurial journey, the founding of Audien Hearing, and the company’s mission to disrupt the hearing aid market by providing affordable, high-quality hearing aids to millions.

In the interview, Ishan discusses how Audien Hearing has become a game-changer in the $7.5 billion hearing aid industry by offering hearing aids at prices as low as $100, making them accessible to a wide audience. Audien Hearing, which launched in 2019, has already reached over 600,000 customers and was the first hearing aid OTC company to launch nationwide in retail.

Ishan shares insights into his typical day, emphasizing the importance of structured routines and maintaining a customer-centric focus. He explains how Audien has scaled efficiently using a proprietary digital customer acquisition model and in-house fulfillment system, allowing the company to grow rapidly while staying true to its mission.

During the interview, Ishan also talks about the value of innovation in the healthcare industry, the importance of listening to customer feedback, and how affordability does not have to mean a compromise in quality.

About Ishan Patel

Ishan Patel is the CEO and Co-Founder of Audien Hearing, a company dedicated to making high-quality hearing aids affordable for everyone. Under his leadership, Audien Hearing has become a leader in the hearing aid industry, offering cutting-edge technology at accessible prices. With over 600,000 satisfied customers and partnerships with national retailers, Ishan continues to push boundaries in the healthcare technology space.

To read the full interview, click here.

Media Contact
Company Name: Audien Hearing
Email: Send Email
City: Scottsdale
State: AZ
Country: United States
Website: https://audienhearing.com/